APOGEE ENTERPRISES, INC.
For the period ended Nov 29, 2025. Filed Jan 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Nov 29, 2025 · Filed Jan 7, 2026
APOG$48.05+5.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
| Nine Months Ended | ||
|---|---|---|
| (In thousands) | November 29, 2025 | November 30, 2024 |
| Operating Activities | ||
| Net earnings | $37,511 | $82,566 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | ||
| Depreciation and amortization | 37,456 | 30,798 |
| Share-based compensation | 6,570 | 8,067 |
| Deferred income taxes | 16,762 | 5,109 |
| Loss on disposal of property, plant and equipment | 418 | 159 |
| Impairment on intangible assets | 7,418 | — |
| Settlement of New Markets Tax Credit transaction | (6,740) | — |
| Non-cash lease expense | 10,901 | 9,926 |
| Other, net | 4,596 | 1,800 |
| Changes in operating assets and liabilities, net of business acquired: | ||
| Receivables | 9,431 | (2,191) |
| Inventories | (9,842) | (8,284) |
| Contract assets | 5,317 | (8,168) |
| Accounts payable | (3,873) | 6,796 |
| Accrued compensation and benefits | (14,782) | (20,958) |
| Contract liabilities | 7,823 | 11,499 |
| Operating lease liability | (10,628) | (9,387) |
| Accrued income taxes | (3,279) | (6,498) |
| Other current assets and liabilities | (28,437) | (6,104) |
| Net cash provided by operating activities | 66,622 | 95,130 |
| Investing Activities | ||
| Capital expenditures | (18,315) | (24,696) |
| Proceeds from sales of property, plant and equipment | 1,606 | 744 |
| Purchases of marketable securities | (550) | (2,394) |
| Sales/maturities of marketable securities | 1,485 | 2,370 |
| Acquisition of business, net of cash acquired | — | (233,125) |
| Net cash used in investing activities | (15,774) | (257,101) |
| Financing Activities | ||
| Proceeds from revolving credit facilities | 80,000 | 95,201 |
| Repayment on revolving credit facilities | (110,000) | (115,201) |
| Proceeds from term loans | — | 250,000 |
| Repayment of term loans | — | (20,000) |
| Repurchase of common stock | — | (15,061) |
| Dividends paid | (16,567) | (16,238) |
| Payments of debt issuance costs | — | (3,798) |
| Other, net | (5,342) | (5,884) |
| Net cash (used in) provided by financing activities | (51,909) | 169,019 |
| Effect of exchange rates on cash | 928 | (409) |
| (Decrease) increase in cash, cash equivalents and restricted cash | (133) | 6,639 |
| Cash, cash equivalents and restricted cash at beginning of period | 41,448 | 37,216 |
| Cash and cash equivalents at end of period | $41,315 | $43,855 |
| Non-cash Activity | ||
| Capital expenditures in accounts payable | $970 | $2,299 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.